Fact-checked by Grok 2 weeks ago

Fasciculation

Fasciculation, commonly known as muscle twitching, is the involuntary, spontaneous contraction of a small bundle of muscle fibers innervated by a single , often manifesting as a fine, visible , ripple, or dimpling beneath the skin without sufficient force to produce joint movement. These contractions are typically brief, lasting milliseconds to seconds, and painless, arising from hyperexcitability of the peripheral nerve or . While often benign and self-limiting, fasciculations can occur in isolation or as part of broader neuromuscular syndromes. The most common causes of fasciculations are non-pathological, including physical or emotional , excessive or stimulant intake, , vigorous exercise, or medication side effects such as those from corticosteroids or diuretics. Nutrient deficiencies, particularly , or metabolic disturbances like low () or low blood sugar can also trigger them. In contrast, persistent or widespread fasciculations may indicate underlying disorders, such as including (), where they represent an early sign of lower motor neuron degeneration; ; peripheral neuropathies; or autoimmune conditions like Isaacs' syndrome or cramp-fasciculation syndrome. Diagnosis typically involves a thorough clinical history, , and (EMG) to assess muscle electrical activity and distinguish benign from pathological causes. Treatment focuses on addressing any identifiable underlying condition, such as correcting electrolyte imbalances or managing neurological diseases, while benign cases often require no intervention beyond lifestyle modifications like reducing or stress. Persistent fasciculations accompanied by , , cramps, or sensory changes necessitate prompt medical evaluation to exclude serious pathology.

Overview

Definition

Fasciculations are involuntary, visible contractions of small groups of muscle fibers, appearing as fine, rapid, and intermittent twitches beneath the skin, often likened to worm-like or vermicular movements. These contractions arise from the spontaneous firing of a single , involving a limited number of muscle fibers innervated by that unit, and are typically too subtle to produce joint movement but sufficient to cause a visible ripple or dimpling on the skin surface. Fasciculations must be distinguished from other involuntary muscle activities, such as , which manifests as continuous, undulating, or rippling movements due to repetitive firing of muscle fiber groups; , involving abrupt, jerky contractions of entire muscles or muscle groups that can displace limbs; and muscle cramps, which are prolonged, sustained, and often painful contractions affecting larger muscle portions. The phenomenon was first systematically described in during the early , with pioneering electromyographic studies by neurologists Derek Denny-Brown and J.B. Pennybacker in 1938, who differentiated fasciculation potentials from fibrillations and established their association with activity. These observations laid the groundwork for understanding fasciculations as a distinct neuromuscular event. Common sites include the eyelids, calves, and thumbs.

Clinical Presentation

Fasciculations manifest as brief, visible, and involuntary contractions of small groups of muscle fibers, typically lasting milliseconds per individual and often appearing as fine, rapid, or worm-like movements. These twitches are generally painless, though some patients describe accompanying sensations of tingling, numbness, or heightened awareness of the muscle activity without overt discomfort. The frequency and duration of fasciculation episodes vary considerably among individuals, ranging from sporadic events occurring once daily to more persistent patterns with multiple twitches per hour; episodes themselves may cluster and last from seconds to minutes. In benign cases, these occurrences can persist intermittently over months or years without progression to weakness or other deficits. Common sites for fasciculations include the eyelids, which represent the most frequent location in benign presentations, as well as the lower limbs (particularly calves and thighs) and upper limbs (such as thumbs and fingers). Less commonly, they affect areas like the or , often remaining localized or migrating between sites. Associated subjective complaints frequently involve anxiety triggered by the persistent or noticeable twitching, prompting patients to seek medical evaluation due to fears of underlying neurological conditions; this health anxiety can in turn exacerbate the frequency or perceived intensity of the symptoms. In most cases, fasciculations are benign and do not indicate serious pathology.

Pathophysiology

Normal Mechanisms

Fasciculations in healthy individuals arise from spontaneous depolarizations of lower motor neurons, particularly alpha motor neurons in the or their peripheral axons, which briefly activate a small group of muscle fibers within a . These discharges are irregular and occur at low frequencies, typically less than 5 Hz, without involving widespread . In benign cases, such activity reflects normal variability in neuronal membrane stability rather than any underlying . The physiological hyperexcitability underlying these events may stem from mechanisms such as afterdepolarizations at nerve terminals, where residual following an triggers additional firing, or ephaptic transmission between adjacent , allowing electrical crosstalk to initiate spontaneous activity. These processes occur at distal sites like axon terminals or proximal locations within the pool, contributing to the visible twitches without compromising motor function. Everyday factors can exacerbate this normal hyperexcitability; physical exercise induces that heightens spontaneous discharges, caffeine enhances neuronal excitability by blocking receptors, and disrupts membrane potentials, increasing twitch frequency. Unlike pathological states, benign fasciculations involve no structural damage to neurons or muscles and resolve spontaneously without medical intervention.

Pathological Mechanisms

In pathological states, fasciculations often stem from disruptions in motor neuron integrity, particularly through degeneration of upper and lower s as seen in (ALS). This process involves progressive loss of anterior horn cells in the , leading to of fibers and heightened sensitivity at the , known as denervation hypersensitivity. The resulting instability triggers ectopic spontaneous firing from surviving motor axons, producing repetitive muscle twitches that can precede overt weakness by months. Ion channel dysfunction represents another key mechanism, exemplified by acquired or Isaacs' syndrome, where autoantibodies target (VGKC) complexes, including proteins like CASPR2 and LGI1. This impairs potassium efflux, causing prolonged and membrane hyperexcitability in peripheral motor nerves, which generates continuous ectopic discharges and fasciculations alongside and stiffness. Electrodiagnostic studies confirm this through after-discharges on , reflecting nerve instability rather than central involvement. Neurotoxic exposures can induce fasciculations by altering inhibitory or mimicking neurodegenerative processes. Strychnine, a , blocks inhibitory postsynaptic potentials in spinal , leading to unopposed excitatory activity and widespread muscle twitching that evolves into tetanic spasms. Similarly, exposure to like mercury can produce fasciculations through axonal degeneration and oxidative damage to motor neurons, often resolving upon cessation of exposure in cases mimicking . Pathological fasciculations also differ by origin, with peripheral mechanisms predominating in conditions like , where compressive injury to roots irritates lower motor neurons, causing localized ectopic activity and in affected myotomes. In contrast, central lesions such as involving upper motor neurons may rarely trigger fasciculations through of spinal circuits, though these are typically overshadowed by and less persistent than peripheral forms.

Causes and Risk Factors

Benign Causes

Fasciculations are commonly triggered by lifestyle factors that temporarily increase excitability without indicating underlying . High intake, such as exceeding 400 mg per day from sources like or energy drinks, can stimulate the and lead to muscle twitches in otherwise healthy individuals. use, particularly through , acts as a that heightens activity, resulting in benign fasciculations that subside upon cessation. Strenuous exercise, such as intense workouts or prolonged , can provoke twitches during recovery periods due to metabolic stress on muscle fibers and , with a temporary increase observed in about 25% of healthy individuals and typically resolving within hours to days. These triggers are reversible by reducing exposure, highlighting their non-serious nature. Mild metabolic imbalances also contribute to benign fasciculations by disrupting normal neuromuscular function. Hypomagnesemia, or low magnesium levels often from dietary insufficiency or medication effects, can cause spontaneous muscle contractions through heightened neuronal excitability, affecting about 2-15% of the general population and correcting with supplementation. Dehydration, frequently induced by diuretic use in conditions like hypertension, leads to electrolyte shifts that promote twitches, particularly in the limbs, and is common among athletes or those in hot environments, with symptoms alleviating upon rehydration. Such imbalances are prevalent and self-limiting when addressed promptly, underscoring their benign profile. Benign fasciculation syndrome (BFS) represents an idiopathic condition characterized by widespread, persistent muscle twitches in healthy individuals, often without identifiable triggers beyond everyday stressors. BFS primarily affects young adults, especially in high-stress professions like healthcare, manifesting as intermittent twitches in the eyelids, calves, or hands, accompanied by subjective but preserved muscle strength. Frequently linked to anxiety or , which amplifies perception of symptoms, BFS impacts up to 70% of reported cases in non-neurological populations and remains stable over time without progression. Its commonality and lack of associated weakness emphasize its harmless, reversible essence through or reassurance. Post-viral or fatigue-related fasciculations arise as temporary responses to bodily stressors, resolving spontaneously in most cases. In cases of benign fasciculations, a preceding common like is reported in about 12% of patients, with twitches arising as a transient response to hyperexcitability and typically fading within weeks. Overexertion or from similarly induces these benign twitches by elevating free radical production and depleting energy stores in muscles, a reversible state that affects active or stressed populations and normalizes with rest. These episodes are widespread, self-resolving, and do not herald issues, reinforcing their non-pathological status.

Serious Causes

Fasciculations serve as an early indicator in , particularly (ALS), where they occur in approximately 56% of patients and often precede or accompany and . In ALS, these involuntary twitches arise from the degeneration of upper and lower motor neurons, leading to spontaneous firing of motor units, and are typically widespread, involving limbs, trunk, and bulbar muscles. Diagnosis of ALS requires correlating fasciculations with progressive weakness, as isolated twitching alone is insufficient but gains significance when combined with electromyographic evidence of . Peripheral neuropathies such as (MMN) can present with focal fasciculations, affecting up to 40% of patients, often in the distal upper limbs alongside asymmetric weakness and minimal sensory involvement. These twitches result from conduction blocks in motor nerves, distinguishing MMN from through the absence of signs and responsiveness to immunomodulatory therapy, though fasciculations may persist. Similarly, (CIDP) features fasciculations in about 40% of cases, typically proximal and symmetric, linked to demyelination-induced nerve hyperexcitability and often accompanied by areflexia and elevated protein in . Autoimmune disorders like Isaac's syndrome, also known as , are characterized by continuous, widespread fasciculations due to autoantibodies targeting voltage-gated potassium channels, resulting in peripheral nerve hyperexcitability. Patients experience muscle stiffness, cramps, and , with fasciculations visible even during sleep, and the condition may be paraneoplastic or idiopathic, requiring antibody testing for confirmation. Other serious conditions include , where fasciculations, particularly in the , accompany proximal weakness and hypotonia from loss, especially in infantile forms. Kennedy's disease, or spinobulbar muscular atrophy, features prominent perioral and fasciculations alongside bulbar dysfunction and due to gene mutations. Paraneoplastic syndromes may also manifest with fasciculations, often with or sensory changes, stemming from autoimmune responses to underlying malignancies like .

Risk Factors

Fasciculations are more prevalent in older adults, with studies using ultrasonography detecting them in 43% of healthy individuals overall, and subjects exhibiting fasciculations being significantly older than those without. This age-related increase, often observed beyond 50 years, may stem from natural changes in neuronal excitability, though the effect remains somewhat variable across populations. Males also show a slightly higher incidence, particularly in cases of (BFS), where affected individuals are predominantly men in their 30s to 60s. Lifestyle factors play a notable role in heightening the risk, including and anxiety disorders, which can precipitate or exacerbate muscle twitches through heightened activity. High levels of , such as strenuous exercise, temporarily increase fasciculation frequency, especially in lower leg muscles, while exposure to stimulants like excessive intake aggravates the condition in susceptible individuals. Similarly, alcohol withdrawal is associated with involuntary muscle twitching due to overactivity during . Certain elements of elevate vulnerability, such as recent viral illnesses, which have been reported to trigger acute onset of fasciculations in up to 16% of benign cases. dysfunction, including , can manifest with fasciculations alongside muscle cramps and weakness, though they are uncommon and typically affect distal muscles. Medication use further contributes, with corticosteroids inducing benign fasciculations through effects on muscle excitability, and beta-agonists, often prescribed for , similarly promoting twitches via adrenergic stimulation. Genetic predisposition underlies rare familial forms of fasciculations, primarily linked to ion channelopathies such as mutations in the SCN4A gene causing sodium channel myotonia or paramyotonia congenita, which enhance muscle membrane excitability. These hereditary disorders, including those involving chloride (CLCN1) or potassium (KCNJ2) channels, lead to hyperexcitability syndromes with fasciculations as a key feature, though most fasciculations remain sporadic without genetic basis.

Diagnosis

History and Physical Examination

The evaluation of fasciculations begins with a detailed patient history to characterize the twitching and identify potential underlying factors. Clinicians inquire about the onset of symptoms, whether sudden or gradual, and the duration and frequency of episodes, which may range from intermittent to persistent. Distribution is assessed by noting affected muscle groups, such as limbs, eyelids, or calves, and whether the twitching is focal, multifocal, or migratory. Associated symptoms are explored, including , numbness, cramps, , or sensory changes like paresthesias, as these may indicate broader neurological involvement. Triggers such as physical exercise, , caffeine intake, or are also documented, as they commonly precipitate benign fasciculations. Red flags in the history prompt urgent evaluation for serious conditions like amyotrophic lateral sclerosis (ALS). Progressive , unexplained , or bulbar symptoms—such as fasciculations, , or —raise concern for disease. Family history of neurodegenerative disorders or recent infections may further heighten suspicion. In contrast, isolated twitching without these features often aligns with benign causes, allowing for initial reassurance. The focuses on non-invasive bedside assessment to observe fasciculations and evaluate neuromuscular integrity. Twitches are best visualized during muscle relaxation, using oblique lighting to enhance visibility, particularly in the calves, eyelids, or , where the patient is asked to rest without voluntary contraction. assesses muscle firmness and texture for signs of underlying tension or early . A comprehensive neurological screening follows, testing muscle strength via manual resistance (e.g., Medical Research Council scale), deep tendon reflexes for hyper- or , and coordination to detect subtle deficits. Sensory examination rules out associated abnormalities like numbness. This history and play a pivotal role in distinguishing from pathological cases, providing reassurance when , , or sensory deficits are absent. Normal findings, such as preserved strength and reflexes with twitching limited to common sites like the calves, support a benign without immediate need for advanced testing. Conversely, any concerning features guide further investigation to exclude serious disorders.

Electrophysiological Studies

Electrophysiological studies play a crucial role in confirming the presence of fasciculations and distinguishing benign from pathological causes by providing objective, quantitative assessments of muscle and nerve function. These tests, primarily performed in a laboratory, include (EMG) and nerve conduction studies (NCS), with single-fiber EMG used in select cases to evaluate integrity. Electromyography (EMG) is the cornerstone for detecting fasciculations, involving the insertion of a concentric needle into the muscle to record spontaneous electrical activity at rest. Fasciculation potentials appear as brief, spontaneous discharges of entire motor units, typically lasting 5-15 ms, with polyphasic waveforms in pathological cases due to reinnervation or axonal damage. These potentials are distinguished from , which produces synchronized, high-amplitude bursts across multiple motor units, and from movement artifacts, which lack the characteristic irregular firing pattern (0.1-10 Hz) and "popcorn popping" audio signature of fasciculations. In routine needle EMG, fasciculations are graded by frequency and distribution, from rare (1+) to continuous (4+), aiding in localization to specific muscle groups. Nerve conduction studies (NCS) complement EMG by evaluating the integrity of peripheral nerves, helping to rule out underlying neuropathy that could contribute to fasciculations. These studies measure motor and conduction velocities (typically 40-60 m/s in upper limbs for healthy adults) and amplitudes, identifying slowing or reduced responses indicative of demyelination or axonal loss in peripheral neuropathies. In isolated fasciculations without neuropathy, NCS findings are normal, supporting a benign , whereas abnormalities such as prolonged distal latencies or low amplitudes may prompt further investigation for conditions like disease or . Single-fiber EMG (SFEMG) is a specialized technique employed when neuromuscular disorders are suspected as a cause of fasciculations, offering higher sensitivity than routine EMG for subtle defects. It records action potentials from individual muscle fibers within the same using a small single-fiber needle, quantifying (variability in interpotential intervals, normally <55 μs in extensor digitorum communis) and blocking (failure of ). Increased or blocking, often exceeding 70 μs mean consecutive difference, indicates impaired synaptic function, as seen in , where fasciculations may arise from unstable endplate potentials. This test is particularly useful in clinically normal muscles, where routine EMG might be unremarkable. The utility of these studies lies in their ability to differentiate benign from pathological fasciculations through recruitment patterns and associated abnormalities. In , EMG reveals isolated fasciculation potentials with normal voluntary (firing rate to motor unit action potential ratio ≈5:1) and no evidence of , such as fibrillation potentials. Pathological fasciculations, conversely, often accompany fibrillation potentials—brief (1-5 ms), regular spikes signaling acute —and reduced due to motor neuron loss, as in , where complex, polyphasic fasciculations predominate. This differentiation guides prognosis and management, with normal studies reassuring against serious pathology.

Management and Treatment

Benign Fasciculation Syndrome

Benign fasciculation syndrome (BFS) is an idiopathic condition characterized by persistent, spontaneous muscle twitches without evidence of underlying neurological , often managed through reassurance and supportive measures rather than aggressive . Diagnosis typically requires the presence of ongoing fasciculations lasting months to years, in the absence of objective , , or other neurological deficits, with (EMG) showing normal findings except for the fasciculation potentials themselves. Associated features frequently include subjective complaints such as perceived weakness, sensory disturbances like tingling or numbness, muscle cramps, and heightened anxiety, which may exacerbate the symptoms but do not indicate progression to serious . Initial management emphasizes modifications to mitigate triggers and reduce symptom intensity. Patients are advised to reduce or avoid intake, as it can worsen fasciculations, and to prioritize adequate sleep of 7-9 hours per night to address fatigue-related exacerbations. techniques, including practices, , or , are recommended to alleviate anxiety, which is present in up to 30% of cases and often amplifies the perception of twitching. These non-pharmacological strategies form the cornerstone of care, promoting overall well-being without the need for invasive procedures. For individuals with severe or disruptive symptoms unresponsive to lifestyle changes, pharmacological options may be considered on a case-by-case basis, though evidence supporting their efficacy remains largely anecdotal and derived from small studies or case reports. Low-dose beta-blockers, such as at 10-40 mg daily, can provide symptomatic relief by reducing anxiety-driven twitches, while anticonvulsants like or may help stabilize nerve excitability in select patients. These agents are typically used sparingly due to potential side effects and the lack of robust clinical trials demonstrating consistent benefits. The for BFS is excellent, with no of progression to like ; symptoms often wax and wane over years but remain benign and non-degenerative. In prospective studies, fasciculations persist in over 95% of patients after two years, yet associated morbidity is primarily psychological rather than physical, resolving with targeted anxiety management in many cases. Benign fasciculations occur in up to 70% of healthy individuals at some point, while (BFS), characterized by persistent symptoms, is less common and affects a smaller subset of the population.

Treatment of Underlying Conditions

Treatment of pathological fasciculations primarily involves addressing the underlying etiology to mitigate symptoms and slow disease progression where possible. In motor neuron diseases such as amyotrophic lateral sclerosis (ALS), disease-modifying therapies like riluzole, administered at 50 mg twice daily, reduce glutamate-induced excitotoxicity and modestly extend survival by slowing motor neuron degeneration. For specific genetic forms, such as SOD1-mutant ALS, targeted therapies like tofersen (Qalsody), approved in 2023, may be used to slow progression and manage symptoms including fasciculations. Similarly, edaravone is recommended for select patients to decelerate functional decline, though its impact on fasciculations specifically remains supportive rather than curative. For associated muscle cramps and fasciculations, symptomatic relief can be achieved with sodium channel blockers such as mexiletine, which stabilizes neuronal membranes and reduces ectopic discharges. Quinine sulfate may also be used for cramp management in these cases, targeting hyperexcitability, although its use is limited due to serious risks such as thrombocytopenia and is not recommended for routine treatment by the FDA. In autoimmune conditions linked to fasciculations, such as or (CIDP), therapies focus on modulating the immune response to target autoantibodies affecting peripheral nerves. Intravenous immunoglobulin (IVIG) is a first-line option, providing rapid symptom improvement by neutralizing pathogenic antibodies and reducing neuromuscular hyperexcitability. , involving 5-7 exchanges, effectively removes circulating autoantibodies and is particularly beneficial in acute exacerbations of neuromyotonia. These interventions aim to alleviate fasciculations by restoring nerve membrane stability, with often combined with membrane-stabilizing agents like for enhanced control. Metabolic derangements causing fasciculations, including imbalances, require prompt correction to resolve symptoms. Hypomagnesemia, a common trigger, is treated with magnesium supplementation to normalize levels and diminish muscle . or other imbalances may necessitate intravenous replacement alongside to prevent recurrent fasciculations. When fasciculations stem from medications such as inhibitors inducing hypomagnesemia, discontinuation of the offending agent is essential, often leading to rapid resolution upon switching to alternatives. A multidisciplinary approach enhances outcomes in degenerative conditions with fasciculations, integrating targeted therapies with supportive measures. helps maintain muscle function and mobility, reducing secondary complications from weakness. Nutritional support, including dietary modifications and supplementation, addresses malnutrition risks in progressive , indirectly supporting overall neuromuscular health.

Epidemiology and Prognosis

Prevalence and Distribution

Fasciculations occur frequently in the general population, with up to 70% of healthy adults reporting occasional episodes based on self-reported surveys. More objective assessments using muscle ultrasonography have detected fasciculations in approximately 43% of healthy individuals, often sporadically and without clinical significance. Benign fasciculation syndrome (BFS), characterized by persistent and widespread fasciculations, represents a subset of these cases, though precise prevalence estimates for BFS remain limited due to variability in diagnostic criteria and reporting. The occurrence of fasciculations increases with age, with older adults exhibiting a higher likelihood of detection compared to younger individuals. For instance, studies have shown a significant age-related rise, potentially linked to physiological changes in excitability. Fasciculations are also slightly more common in males than females, particularly in cohorts presenting with persistent symptoms. Anatomically, fasciculations in healthy individuals most commonly affect the lower extremities, particularly the calves and foot muscles such as the abductor hallucis longus, followed by the eyelids and upper extremities including the arms and hands. They are rare in the or proximal muscles above the . Recent post-2020 ultrasound studies have quantified higher detection rates in the lower legs (approximately 13-14%) compared to the upper legs (9-10%), with influenced by factors like recent exercise. These findings highlight the distal predominance of benign fasciculations and underscore the utility of for precise mapping.

Prognosis

The prognosis of fasciculations varies significantly depending on their underlying , with benign cases generally carrying an excellent outlook and pathological cases showing more heterogeneous outcomes. In (BFS), fasciculations typically persist over time but do not progress to disease or other serious neurological conditions; long-term follow-up studies of over 100 patients have reported no instances of symptomatic disease development after 2 to 32 years. While complete resolution is uncommon, with fasciculations continuing in approximately 98% of cases, symptomatic improvement occurs in about 52% of individuals, often stabilizing without intervention. Although BFS is not associated with progression to anxiety disorders, affected patients frequently experience health-related anxiety due to symptom persistence, which can be managed supportively. In pathological cases, outcomes are etiology-specific and often more guarded. For instance, fasciculations occurring in (ALS) are linked to a survival of 2 to 5 years from symptom onset, with wide individual variation influenced by factors such as age and site of onset. In autoimmune-mediated conditions like Isaac's syndrome (a form of featuring prominent fasciculations), the is more favorable with ; such as rituximab or intravenous immunoglobulin leads to substantial symptom remission or long-term improvement in the majority of cases, particularly when initiated early and in non-paraneoplastic forms. Overall, pathological fasciculations require targeted management of the underlying disorder to optimize outcomes. Several factors influence the across etiologies. Early diagnosis facilitates timely intervention, particularly in treatable pathological cases, thereby improving and potentially extending survival. The absence of or at presentation strongly predicts a benign course, with isolated fasciculations carrying a high likelihood (over 95% in studies) of remaining non-progressive. For persistent benign cases, long-term with annual neurological evaluations is recommended to identify any rare progressions, though the risk of BFS evolving into is exceedingly low, estimated at less than 1% based on extensive follow-up data.

References

  1. [1]
    Fasciculation - MeSH - NCBI
    ### Definition and Key Information
  2. [2]
    Another Perspective on Fasciculations - PubMed Central - NIH
    The fasciculations can be defined as visible fast, fine, spontaneous and intermittent contractions of muscle fibers. Some neurologists call them verminosis, ...
  3. [3]
    Muscle twitching: MedlinePlus Medical Encyclopedia
    Mar 31, 2024 · Muscle twitching is caused by minor muscle contractions in the area, or uncontrollable twitching of a muscle group that is served by a single motor nerve fiber.
  4. [4]
    Fasciculation differences between ALS and non-ALS patients - NIH
    Nov 10, 2021 · Abstract. Background. Fasciculation is an important sign for the diagnosis of amyotrophic lateral sclerosis (ALS).
  5. [5]
    Fasciculation - MeSH - NCBI - NIH
    Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations may be visualized as a muscle twitch or dimpling under the skin.
  6. [6]
    Differentiating fasciculations from myoclonus in motor neuron disease
    Dec 20, 2017 · Fasciculations, on the other hand cause visible twitches of a portion of an individual muscle. As opposed to myoclonus, they are too small to ...Missing: definition | Show results with:definition
  7. [7]
    Myokymia – Knowledge and References - Taylor & Francis
    Myokymia is a condition characterized by persistent spontaneous rippling and quivering of muscles at rest, caused by groups of repetitive firing potentials.<|control11|><|separator|>
  8. [8]
    Muscle Cramps: Causes, Treatments & Insights - - Practical Neurology
    2019年7月19日 · A muscle cramp is a hyperexcitable neurologic phenomena of excessive, involuntary muscle contractions.
  9. [9]
    Denny-Brown and Pennybacker: 80 years after their pioneering ...
    Denny-Brown and Pennybacker: 80 years after their pioneering article on electromyography, fibrillation and fasciculation. Arq Neuropsiquiatr. 2021 Jan;79(1): ...
  10. [10]
    Muscle twitching Information | Mount Sinai - New York
    Twitches not caused by disease or disorders (benign twitches), often affecting the eyelids, calf, or thumb. These twitches are normal and quite common, and are ...
  11. [11]
    Benign Fasciculation Syndrome: Symptoms & Treatment
    Fasciculation (muscle twitching) happens when a single peripheral nerve that controls a muscle is overactive, resulting in involuntary muscle movement.
  12. [12]
    A prospective study of benign fasciculation syndrome and anxiety
    ... benign fasciculation syndrome (BFS), patients are often anxious about their symptoms. ... Commonly associated symptoms include subjective weakness, sensory ...
  13. [13]
    Clinical Mimickers of Amyotrophic Lateral Sclerosis-Conditions We ...
    LOWER MOTOR NEURON ONLY SIGNS. Benign fasciculation syndrome. Benign fasciculation syndrome is a commonly encountered differential for motor neuron disorders.
  14. [14]
    Benign fasciculations: A follow-up study with electrophysiological ...
    Sep 17, 2021 · Benign fasciculations: A follow-up study with electrophysiological studies. Muscle Nerve. 2021 Dec;64(6):670-675. doi: 10.1002/mus.27411 ...
  15. [15]
    Muscle Action Potential - an overview | ScienceDirect Topics
    It is possible that ephaptic transmission across these fibers could produce fasciculatory movements. Idiopathic “benign” fasciculations and muscle cramps often ...<|control11|><|separator|>
  16. [16]
    Origin of Fasciculations in Amyotrophic Lateral Sclerosis and Benign ...
    Denny-Brown and Pennybacker,2 who first addressed this question, considered that fasciculations probably arose from anterior horn cells but Forster et al3 ...
  17. [17]
  18. [18]
    Isaacs' syndrome: Clinical and paraclinical perspectives in a series ...
    Dysfunction of voltage-gated potassium channels (VGKCs)-complex proteins is the main cause of Isaacs' syndrome pathophysiology, which could be associated with ...
  19. [19]
    Strychnine Toxicity - StatPearls - NCBI Bookshelf - NIH
    Strychnine is responsible for inhibiting postsynaptic glycine receptors, mostly in the spinal cord, causing painful, involuntary skeletal muscle spasms.Strychnine Toxicity · Pathophysiology · Toxicokinetics
  20. [20]
  21. [21]
  22. [22]
    Benign Fasciculation Syndrome: Causes and Treatment
    Benign fasciculations can often happen after drinking too much caffeine or smoking (due to the stimulant effect of nicotine).
  23. [23]
  24. [24]
    Hypomagnesemia - StatPearls - NCBI Bookshelf - NIH
    Nov 30, 2023 · Hypomagnesemia is an electrolyte disturbance caused by a low serum magnesium level of less than 1.46 mg/dL in the blood.Etiology · Pathophysiology · Evaluation · Treatment / Management
  25. [25]
  26. [26]
    Long-term follow-up of 121 patients with benign fasciculations
    A subset of 19 patients described acute onset of fasciculations following a viral infection. Benign fasciculations are not a preclude to progressive motor ...
  27. [27]
    Benign fasciculations and corticosteroid use - PubMed Central - NIH
    Fasciculations are characterized by visible subtle and fast contractions of muscle, even wormlike in movement, by the contraction of a fascicle of muscle ...
  28. [28]
    Clinical characteristics of a large cohort of US participants enrolled ...
    Other symptoms ever experienced included cramps (56.7%), fasciculations (56.3%), and dysarthria (33.0%). The median time between an increase of muscle cramps ...
  29. [29]
    The rise and fall of fasciculations in amyotrophic lateral sclerosis
    Fasciculations represent an early pathophysiological hallmark of amyotrophic lateral sclerosis and can be reliably detected by high-density surface ...
  30. [30]
    The rise and fall of fasciculations in amyotrophic lateral sclerosis
    Feb 20, 2020 · Compared with benign fasciculation syndrome, biceps fasciculation frequency in amyotrophic lateral sclerosis was 10 times greater in strong ...Missing: prevalence | Show results with:prevalence
  31. [31]
    Difference in distribution of fasciculations between multifocal motor ...
    Results: Fasciculation detection rates on the onset side were significantly higher in ALS (42.4 ± 18.3%, mean ± SD) than in MMN (21.9 ± 8.8%) patients (p < 0.05) ...Missing: prevalence | Show results with:prevalence
  32. [32]
    Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
    Apr 5, 2024 · Chronic inflammatory demyelinating polyneuropathy (CIDP) ... Cramps and fasciculations can be seen in 40% of cases, and cold aggravates weakness.
  33. [33]
    Mechanism of action of voltage-gated K+ channel antibodies in ...
    Acquired neuromyotonia (ANM) is associated with antibodies to voltage-gated K+ channels (VGKCs). ANM sera reduce the number of K+ currents in neuronal cell ...
  34. [34]
    Acquired Neuromyotonia - Symptoms, Causes, Treatment | NORD
    Jul 23, 2024 · Acquired neuromyotonia is characterized by involuntary continuous muscle fiber activity (fasciculations, doublet and triplet discharges on ...Acknowledgment · Programs & Resources · Rare Disease Educational...
  35. [35]
    Tongue fasciculations in an infant with spinal muscular atrophy type 1
    Sep 2, 2015 · The presence of tongue fasciculations in combination with a thorough history may be suggestive of SMA.
  36. [36]
    Spinal and bulbar muscular atrophy - Genetics - MedlinePlus
    Jun 1, 2020 · Additionally, muscle twitches (fasciculations) are common. Some males with the disorder experience unusual breast development (gynecomastia) ...
  37. [37]
    Paraneoplastic neurological syndromes - PMC - PubMed Central
    Neuromyotonia (Isaac syndrome) manifests with muscle pain, cramps, fasciculations, stiffness and weakness of trunk and extremities with or without autonomic ...
  38. [38]
    Prevalence and distribution of fasciculations in healthy adults
    Our objective was to determine the prevalence and distribution of fasciculations in healthy adults and to assess the effect of age, caffeine and exercise.
  39. [39]
    Fasciculation distribution in a healthy population assessed with ...
    Mar 22, 2025 · The effect of age on fasciculations is contradictory. Some studies show an increase in fasciculations with age (Fermont et al., 2010 ...
  40. [40]
    Benign Fasciculation Syndrome - Causes, Symptoms, Diagnosis ...
    Apr 25, 2025 · High levels of stress, lack of sleep, and excessive caffeine intake are known to exacerbate muscle twitching.Causes And Risk Factors · Symptoms · Frequently Asked Questions...
  41. [41]
    The Association Between Benign Fasciculations and Health Anxiety
    Benign fasciculation syndrome (BFS) is characterized by persistent spontaneous contractions of muscle fibers in the absence of a pathological cause.
  42. [42]
    Does Alcohol Withdrawal Cause Muscle Twitching and Spasms?
    Tremors that occur after you stop drinking are one of the first signs of alcohol withdrawal. Learn what to expect after you stop drinking.
  43. [43]
    Myopathies associated with thyroid disease | MedLink Neurology
    Feb 4, 2025 · Fibrillations and fasciculations are uncommon but may be found in distal muscles (120). ... Thyroid disease and muscle dysfunction. Chicago ...
  44. [44]
    Benign Fasciculation Syndrome: Symptoms and Treatment
    Jun 22, 2017 · Benign fasciculation syndrome involves involuntary twitching in your eyes, arms, legs, or other body parts. It's usually not a cause for concern.
  45. [45]
    Channelopathies of skeletal muscle excitability - PMC
    These familial disorders of muscle fiber excitability are “channelopathies” caused by mutations of a chloride channel (ClC-1), sodium channel (NaV1.4), calcium ...
  46. [46]
    Fasciculations in human hereditary disease - PubMed
    Jul 30, 2014 · Fasciculations are a manifestation of peripheral nerve hyperexcitability in addition to myokymia, neuromyotonia, cramps, or tetany.
  47. [47]
    History Taking Approach for Fasciculations (Muscle Twitching)
    Sep 3, 2025 · Red flag symptoms (require urgent neurological referral):. Muscle weakness or atrophy; Bulbar symptoms (speech, swallowing difficulties); Loss ...
  48. [48]
    The Motor System and Gait - Clinical Methods - NCBI Bookshelf - NIH
    Fasciculations may be difficult to see in obese patients or infants. It is said that they can best be appreciated with oblique lighting; sometimes lightly ...
  49. [49]
    How to Localize Neurologic Lesions by Physical Examination - NCBI
    Clinical Significance​​ Examination of the motor system of a limb includes checking for muscle bulk and fasciculation, muscle tone at joints, the power of muscle ...
  50. [50]
    Abnormal Spontaneous Electromyographic Activity - StatPearls - NCBI
    Sep 15, 2025 · Key patterns and their defining EMG features are presented below. Fasciculation potentials are spontaneous single motor unit discharges arising ...
  51. [51]
    Electrodiagnostic Evaluation of Peripheral Neuropathy - NCBI - NIH
    Jan 30, 2023 · Electrodiagnostic testing, which includes nerve conduction studies (NCS) and needle electromyography (EMG), can support the diagnosis of peripheral neuropathy.
  52. [52]
    Basic Electromyography: Analysis of Spontaneous Activity
    Mar 1, 2019 · If the motor unit is normal, the MUAP morphology will be normal: typically two to four phases, 5 to 15 ms in duration, and variable amplitude ...<|control11|><|separator|>
  53. [53]
    Characterization of Fasciculation Potentials (FPs) in Amyotrophic ...
    May 3, 2021 · This study is aimed at investigating the features of fasciculation potentials (FPs) in amyotrophic lateral sclerosis (ALS) and peripheral nerve ...
  54. [54]
    EMG and Nerve Conduction Studies in Clinical Practice
    Small, brief and polyphasic MUPs, as well as fibrillation potentials, positive waves and complex repetitive discharges are frequently seen in patients with ...
  55. [55]
    Single-fiber EMG: A review - PMC - NIH
    It must be emphasised that increased jitter values are not pathogonomic for myasthenia, but indicate disturbed neuromuscular transmission.Missing: fasciculations | Show results with:fasciculations
  56. [56]
    Single-Fiber EMG: Overview, Indications, Contraindications
    Mar 13, 2019 · In diseases of abnormal neuromuscular transmission, jitter may be increased in muscles that are clinically normal, showing no decrement to ...Missing: fasciculations | Show results with:fasciculations
  57. [57]
    [PDF] Needle electromyography Fundamentals, normal and abnormal ...
    Jun 2, 2021 · Table 1 summarizes the morphology, stability, and firing characteristics of the common spontaneous potentials seen during the needle EMG.
  58. [58]
    A Prospective Study of Benign Fasciculation Syndrome (S45.007)
    This is a two-year prospective study. Patients seen for fasciculations in the absence of weakness, atrophy, or other neurologic symptoms were eligible.<|control11|><|separator|>
  59. [59]
    Amyotrophic Lateral Sclerosis - StatPearls - NCBI Bookshelf - NIH
    [1][3] Riluzole, 50mg bid, is recommended for all patients with ALS and is thought to reduce glutamate-induced excitotoxicity. Riluzole is the only medication ...
  60. [60]
    Iranian clinical practice guideline for amyotrophic lateral sclerosis
    Treatment with riluzole is strongly recommended for all ALS patients regardless of their disease status (grade A). Edaravone should be considered in selected ...
  61. [61]
    Mexiletine for Muscle Cramps in ALS: A Randomized Double-Blind ...
    No treatment today is proven to be effective against fasciculations. A membrane-stabilizing Na+ channel blocker such as mexiletine may reduce them, and this ...
  62. [62]
    Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from ...
    Mar 16, 2024 · For fasciculations and cramps, quinine sulfate is used in ... Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease.
  63. [63]
    Orphan Peripheral Neuropathies - PMC - PubMed Central - NIH
    Sep 22, 2020 · First-line treatment of CIDP includes steroids, intravenous immunoglobulins, and plasmapheresis.<|control11|><|separator|>
  64. [64]
    Autoimmune Disorders of the Nervous System - PubMed Central - NIH
    Apr 14, 2021 · First line immunotherapy includes high dose intravenous methylprednisolone for 5 days. This is usually followed by plasmapheresis (5–7 exchanges) ...
  65. [65]
    Immune Mediated Diseases and Immune Modulation in the ...
    The mainstay of therapy for patients with neuromyotonia is the use of anti-epileptic drugs that decrease nerve excitability. In addition, high-dose parenteral ...
  66. [66]
    Hypomagnesemia: a clinical perspective - PMC - PubMed Central
    Consultation with a dietitian may be necessary to increase dietary magnesium intake as well as protein supplementation in malnourished patients. Reduction of ...
  67. [67]
    Muscle Cramps - StatPearls - NCBI Bookshelf
    Sep 14, 2025 · Muscle cramps are sudden, involuntary, and painful contractions of a muscle or muscle group, often affecting the lower extremities. Although ...Muscle Cramps · Etiology · Pathophysiology
  68. [68]
    Magnesium: The Forgotten Electrolyte—A Review on ... - NIH
    Patients with hypomagnesemia and on PPIs should consider discontinuing PPIs and switching to alternative medical treatments. Some cases were shown to normalize ...
  69. [69]
    Physical therapy for individuals with amyotrophic lateral sclerosis
    Jul 16, 2018 · Physical therapy is an integral component of the ALS multidisciplinary team and is well grounded in rehabilitation and active living concepts.
  70. [70]
    Nutritional and Microbiota-Based Approaches in Amyotrophic ...
    According to ESPEN guidelines, nutritional deterioration in ALS patients is caused by several factors related to the disease's pathophysiology [118]: (i) bulbar ...
  71. [71]
    Relationship between the occurrence of benign fasciculation…
    The study demonstrated that in our patient cohort BFS occurs in people of younger and middle age, with an average of 39.4 ± 9.7 years, more frequently in males ...Missing: distribution | Show results with:distribution
  72. [72]
    Fasciculation distribution in healthy population with DTI
    Mar 22, 2025 · Fasciculations are random muscle twitches due to the spontaneous activity of motor units. The widespread presence of fasciculations is ...Missing: benign | Show results with:benign